diapep277
Peptideexperimental
Clinical trial activity
7 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
7
Phase 3
5
Phase 4
0
Earliest trial started Oct 1, 2002 (NCT00058981)
Timeline
Indications
Studied for
Mechanism of action
- Heat shock protein HSP 60AGONIST
HSPD1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- diapep277
- diapep277
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01881958 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | Hebrew University |
| NCT01898286 | Phase 3 | Oct 1, 2013 | Andromeda Biotech Ltd., Hebrew University |
| NCT01460251 | Phase 3 | Jan 1, 2012 | Tel Aviv University |
| NCT01103284 | Phase 3 | Apr 1, 2010 | Andromeda Biotech Ltd., Campus Bio-Medico University, Hebrew University, Justus Liebig University Giessen, The University of Texas, Dallas |
| NCT00644501 | Phase 3 | Sep 1, 2008 | Andromeda Biotech Ltd., Hebrew University |
| NCT00615264 | Phase 3 | Sep 1, 2005 | Andromeda Biotech Ltd., Campus Bio-Medico University, Hebrew University, New Groote Schuur Hospital, Cape Town |
| NCT00058981 | Phase 2 | Oct 1, 2002 | DeveloGen AG, Germany, University of Washington |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hebrew University | Academic/Hospital | 5 | 1 | 2 | 2005 |
| Andromeda Biotech Ltd. | For profit | 4 | 4 | 1 | 2005 |
| Campus Bio-Medico University | Academic/Hospital | 2 | 0 | 1 | 2005 |
| DeveloGen AG, Germany | For profit | 1 | 1 | 1 | 2002 |
| Justus Liebig University Giessen | Academic/Hospital | 1 | 0 | 1 | 2010 |
| New Groote Schuur Hospital, Cape Town | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2002 |
9 organizations
Page 1 / 1